Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues?

Buecken R, Galushko M, Golla H, Strupp J, Hahn M, Ernstmann N, Pfaff H, Voltz R.

Patient Educ Couns. 2012 Aug;88(2):318-24. doi: 10.1016/j.pec.2012.03.010. Epub 2012 Apr 4.

PMID:
22480629
2.

Advanced dementia: state of the art and priorities for the next decade.

Mitchell SL, Black BS, Ersek M, Hanson LC, Miller SC, Sachs GA, Teno JM, Morrison RS.

Ann Intern Med. 2012 Jan 3;156(1 Pt 1):45-51. doi: 10.7326/0003-4819-156-1-201201030-00008.

3.

Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained.

Higginson IJ, Costantini M, Silber E, Burman R, Edmonds P.

Postgrad Med J. 2011 Nov;87(1033):769-75. doi: 10.1136/postgradmedj-2011-130290. Epub 2011 Oct 6.

PMID:
21978993
4.

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(9):e24369. doi: 10.1371/journal.pone.0024369. Epub 2011 Sep 8.

5.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

6.

Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life.

Murtagh FE, Sheerin NS, Addington-Hall J, Higginson IJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1580-90. doi: 10.2215/CJN.09021010. Epub 2011 Jun 16.

7.

The use of two common palliative outcome measures in clinical care and research: a systematic review of POS and STAS.

Bausewein C, Le Grice C, Simon S, Higginson I; PRISMA.

Palliat Med. 2011 Jun;25(4):304-13. doi: 10.1177/0269216310395984. Epub 2011 Apr 4. Review.

PMID:
21464119
8.

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR; NMSS Validation Group.

Mov Disord. 2011 Feb 15;26(3):399-406. doi: 10.1002/mds.23462. Epub 2011 Jan 24.

PMID:
21264941
9.

Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study.

Dibble LE, Cavanaugh JT, Earhart GM, Ellis TD, Ford MP, Foreman KB.

BMC Neurol. 2010 Nov 3;10:110. doi: 10.1186/1471-2377-10-110.

10.

Quality of life in Parkinson's disease patients: validation of the Short-Form Eight-item Parkinson's Disease Questionnaire (PDQ-8) in Taiwan.

Huang TT, Hsu HY, Wang BH, Chen KH.

Qual Life Res. 2011 May;20(4):499-505. doi: 10.1007/s11136-010-9777-3. Epub 2010 Oct 24.

PMID:
20972838
11.

Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study.

Bausewein C, Booth S, Gysels M, Kühnbach R, Haberland B, Higginson IJ.

Palliat Med. 2010 Dec;24(8):777-86. doi: 10.1177/0269216310378785. Epub 2010 Sep 16.

PMID:
20847087
12.

Older people living alone at the end of life in the U.K.: research and policy challenges.

Rolls L, Seymour JE, Froggatt KA, Hanratty B.

Palliat Med. 2011 Sep;25(6):650-7. doi: 10.1177/0269216310373165. Epub 2010 Jul 9.

PMID:
20621946
13.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

14.

Psychological well-being and quality of care: a factor-analytic examination of the palliative care outcome scale.

Siegert RJ, Gao W, Walkey FH, Higginson IJ.

J Pain Symptom Manage. 2010 Jul;40(1):67-74. doi: 10.1016/j.jpainsymman.2009.11.326. Epub 2010 May 15.

PMID:
20471782
15.

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.

Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P.

Mov Disord. 2010 Apr 30;25(6):704-9. doi: 10.1002/mds.22868.

PMID:
20437539
16.

Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.

Luo N, Ng WY, Lau PN, Au WL, Tan LC.

Qual Life Res. 2010 May;19(4):565-9. doi: 10.1007/s11136-010-9615-7. Epub 2010 Mar 4.

PMID:
20204708
17.

Multiple system atrophy: an update.

Stefanova N, Bücke P, Duerr S, Wenning GK.

Lancet Neurol. 2009 Dec;8(12):1172-8. doi: 10.1016/S1474-4422(09)70288-1. Review.

PMID:
19909915
18.

Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial.

Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM.

J Pain Symptom Manage. 2009 Dec;38(6):816-26. doi: 10.1016/j.jpainsymman.2009.07.002. Epub .

PMID:
19833477
19.

Recent developments in multiple system atrophy.

Wenning GK, Stefanova N.

J Neurol. 2009 Nov;256(11):1791-808. doi: 10.1007/s00415-009-5173-8. Epub 2009 May 27. Review.

PMID:
19471850
20.

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A.

Mov Disord. 2009 Jul 15;24(9):1325-32. doi: 10.1002/mds.22586.

Items per page

Supplemental Content

Write to the Help Desk